Skip to content

Drug interactions

Avanafil + Tucatinib

Severity: Moderate

Avanafil and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A and may increase avanafil exposure. This may increase hypotension, visual effects and priapism.

What this interaction means in plain words

Avanafil and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Avanafil belongs to Genitourinary; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Tucatinib inhibits CYP3A4, reducing avanafil metabolism.

What to do

Use the lowest effective avanafil dose, within labeled limits for moderate CYP3A inhibitors, and monitor blood pressure and adverse effects. Consider an alternative agent if possible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Avanafil and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Avanafil with Tucatinib?

MediHelp rates the interaction as moderate. Avanafil and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits CYP3A and may increase avanafil exposure. This may increase hypotension, visual effects and priapism.

How serious is the interaction between Avanafil and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the lowest effective avanafil dose, within labeled limits for moderate CYP3A inhibitors, and monitor blood pressure and adverse effects. Consider an alternative agent if possible.

What other medicines interact with Avanafil?

MediHelp also lists interactions of Avanafil with, for example, Amyl nitrite, Atazanavir, Clarithromycin. The full list is on the Avanafil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in